These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22834073)

  • 1. Delivery of siRNA into the blood-brain barrier: recent advances and future perspective.
    Kuwahara H; Yokota T
    Ther Deliv; 2012 Apr; 3(4):417-20. PubMed ID: 22834073
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in the Design of (Nano)Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System.
    Mendonça MCP; Kont A; Aburto MR; Cryan JF; O'Driscoll CM
    Mol Pharm; 2021 Apr; 18(4):1491-1506. PubMed ID: 33734715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. siRNA Therapeutics for Protein Misfolding Diseases of the Central Nervous System.
    Zabel MD; Mollnow L; Bender H
    Methods Mol Biol; 2021; 2282():377-394. PubMed ID: 33928585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
    Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
    Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology.
    Xia CF; Zhang Y; Zhang Y; Boado RJ; Pardridge WM
    Pharm Res; 2007 Dec; 24(12):2309-16. PubMed ID: 17926121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics in blood-brain barrier disruption.
    Ihezie SA; Mathew IE; McBride DW; Dienel A; Blackburn SL; Thankamani Pandit PK
    Fluids Barriers CNS; 2021 Apr; 18(1):17. PubMed ID: 33823899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood-Brain Barrier.
    Stanimirovic DB; Sandhu JK; Costain WJ
    BioDrugs; 2018 Dec; 32(6):547-559. PubMed ID: 30306341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced BBB permeability of osmotically active poly(mannitol-co-PEI) modified with rabies virus glycoprotein via selective stimulation of caveolar endocytosis for RNAi therapeutics in Alzheimer's disease.
    Park TE; Singh B; Li H; Lee JY; Kang SK; Choi YJ; Cho CS
    Biomaterials; 2015 Jan; 38():61-71. PubMed ID: 25457984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of small interfering RNA for central nervous system diseases.
    Lovett-Racke AE; Cravens PD; Gocke AR; Racke MK; Stüve O
    Arch Neurol; 2005 Dec; 62(12):1810-3. PubMed ID: 16344338
    [No Abstract]   [Full Text] [Related]  

  • 10. Inducible and reversible breaching of the blood brain barrier by RNAi.
    Rossi JJ
    EMBO Mol Med; 2011 Apr; 3(4):186-8. PubMed ID: 21394916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crossing the blood-brain-barrier with viral vectors.
    Fu H; McCarty DM
    Curr Opin Virol; 2016 Dec; 21():87-92. PubMed ID: 27591676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for the nervous system: challenges and new strategies.
    Maguire CA; Ramirez SH; Merkel SF; Sena-Esteves M; Breakefield XO
    Neurotherapeutics; 2014 Oct; 11(4):817-39. PubMed ID: 25159276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gene therapy of ALS with short interfering RNA].
    Yokota T
    Brain Nerve; 2007 Oct; 59(10):1187-94. PubMed ID: 17969360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.
    Banks WA
    Nat Rev Drug Discov; 2016 Apr; 15(4):275-92. PubMed ID: 26794270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial of special issue: Blood-CNS and blood-nerve barriers in health and diseases and potential therapy.
    Sheikh KA; Lee JP
    Exp Neurol; 2020 Dec; 334():113440. PubMed ID: 32890971
    [No Abstract]   [Full Text] [Related]  

  • 16. Brain Targeting of siRNA via Intranasal Pathway.
    Mohanty C; Kundu P; Sahoo SK
    Curr Pharm Des; 2015; 21(31):4606-13. PubMed ID: 26486146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging therapeutic role of RNA interference in disorders of the central nervous system.
    Dessy A; Gorman JM
    Clin Pharmacol Ther; 2011 Mar; 89(3):450-4. PubMed ID: 21248728
    [No Abstract]   [Full Text] [Related]  

  • 18. RNAi-mediated reversible opening of the blood-brain barrier.
    Campbell M; Kiang AS; Kenna PF; Kerskens C; Blau C; O'Dwyer L; Tivnan A; Kelly JA; Brankin B; Farrar GJ; Humphries P
    J Gene Med; 2008 Aug; 10(8):930-47. PubMed ID: 18509865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopeptide delivery of siRNA to the central nervous system.
    Zabel MD
    Methods Mol Biol; 2013; 948():251-62. PubMed ID: 23070775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of disease: the blood-brain barrier.
    Neuwelt EA
    Neurosurgery; 2004 Jan; 54(1):131-40; discussion 141-2. PubMed ID: 14683550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.